Attached files
| file | filename |
|---|---|
| EX-5.1 - EXHIBIT 5.1 - TITAN PHARMACEUTICALS INC | tm2037804d1_ex5-1.htm |
| S-1 - FORM S-1 - TITAN PHARMACEUTICALS INC | tm2037804d1_s1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference, in the Prospectus constituting a part of this Registration Statement on Form S-1, of our report dated March 30, 2020, relating to the financial statements of Titan Pharmaceuticals, Inc., appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. Our report contains an explanatory paragraph expressing substantial doubt about the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ OUM & Co. LLP
San Francisco, California
December 7, 2020